Abstract
992P Analyzing effectiveness and safety of standard-dose and low-dose bevacizumab combination with atezolizumab in patients with unresectable hepatocellular carcinoma: a multi-institutional study in Taiwan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have